Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Perspectives on End-of-Life Treatment among Patients with COPD: A Multicenter, Cross-sectional Study in Japan.

Fuseya Y, Muro S, Sato S, Sato A, Tanimura K, Hasegawa K, Uemasu K, Hamakawa Y, Takahashi Y, Nakayama T, Sakai N, Fukui M, Kita H, Mio T, Mishima M, Hirai T.

COPD. 2019 Feb;16(1):75-81. doi: 10.1080/15412555.2019.1573888. Epub 2019 Feb 21.

PMID:
30788987
2.

Annual decline in arterial blood oxygen predicts development of chronic respiratory failure in COPD with mild hypoxaemia: A 6-year follow-up study.

Uemasu K, Sato S, Muro S, Sato A, Tanabe N, Hasegawa K, Hamakawa Y, Mizutani T, Fuseya Y, Tanimura K, Takahashi T, Hirai T.

Respirology. 2019 Mar;24(3):262-269. doi: 10.1111/resp.13402. Epub 2018 Sep 19.

PMID:
30230650
3.

Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model.

Tsuji T, Ozasa H, Aoki W, Aburaya S, Funazo T, Furugaki K, Yoshimura Y, Ajimizu H, Okutani R, Yasuda Y, Nomizo T, Uemasu K, Hasegawa K, Yoshida H, Yagi Y, Nagai H, Sakamori Y, Ueda M, Hirai T, Kim YH.

Mol Cancer Res. 2019 Jan;17(1):212-224. doi: 10.1158/1541-7786.MCR-18-0325. Epub 2018 Aug 31.

PMID:
30171175
4.

Complementary regional heterogeneity information from COPD patients obtained using oxygen-enhanced MRI and chest CT.

Fuseya Y, Muro S, Sato S, Tanabe N, Sato A, Tanimura K, Hasegawa K, Uemasu K, Kubo T, Kido A, Fujimoto K, Fushimi Y, Kusahara H, Sakashita N, Ohno Y, Togashi K, Mishima M, Hirai T.

PLoS One. 2018 Aug 30;13(8):e0203273. doi: 10.1371/journal.pone.0203273. eCollection 2018.

5.

Gastroesophageal reflux symptoms and nasal symptoms affect the severity of bronchitis symptoms in patients with chronic obstructive pulmonary disease.

Hasegawa K, Sato S, Tanimura K, Fuseya Y, Uemasu K, Hamakawa Y, Sato A, Mishima M, Muro S, Hirai T.

Respir Investig. 2018 May;56(3):230-237. doi: 10.1016/j.resinv.2018.01.001. Epub 2018 Feb 14.

PMID:
29773294
6.

Fraction of MHCII and EpCAM expression characterizes distal lung epithelial cells for alveolar type 2 cell isolation.

Hasegawa K, Sato A, Tanimura K, Uemasu K, Hamakawa Y, Fuseya Y, Sato S, Muro S, Hirai T.

Respir Res. 2017 Aug 7;18(1):150. doi: 10.1186/s12931-017-0635-5.

7.

Chronic Kidney Disease Predicts Survival in Patients with Idiopathic Pulmonary Fibrosis.

Ikezoe K, Handa T, Tanizawa K, Yokoi H, Kubo T, Aihara K, Sokai A, Nakatsuka Y, Hashimoto S, Uemasu K, Sato S, Muro S, Nagai S, Yanagita M, Chin K, Hirai T, Taguchi Y, Mishima M.

Respiration. 2017;94(4):346-354. doi: 10.1159/000478787. Epub 2017 Jul 21.

8.

Quantitative Assessment of Erector Spinae Muscles in Patients with Chronic Obstructive Pulmonary Disease. Novel Chest Computed Tomography-derived Index for Prognosis.

Tanimura K, Sato S, Fuseya Y, Hasegawa K, Uemasu K, Sato A, Oguma T, Hirai T, Mishima M, Muro S.

Ann Am Thorac Soc. 2016 Mar;13(3):334-41. doi: 10.1513/AnnalsATS.201507-446OC.

PMID:
26700501
9.

Emphysema and airway disease affect within-breath changes in respiratory resistance in COPD patients.

Hasegawa K, Sato S, Tanimura K, Fuseya Y, Uemasu K, Sato A, Hirai T, Mishima M, Muro S.

Respirology. 2015 Jul;20(5):775-81. doi: 10.1111/resp.12535. Epub 2015 Mar 30.

Supplemental Content

Loading ...
Support Center